Agency Information Collection Activities: Submission for OMB Review; Comment Request
| Published date | 11 May 2020 |
| Citation | 85 FR 27756 |
| Record Number | 2020-09961 |
| Section | Notices |
| Court | Substance Abuse And Mental Health Services Administration |
Federal Register, Volume 85 Issue 91 (Monday, May 11, 2020)
[Federal Register Volume 85, Number 91 (Monday, May 11, 2020)]
[Notices]
[Pages 27756-27757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09961]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, email or call the SAMHSA Reports Clearance Officer at
[email protected] or (240) 276-0361.
Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx)
Evaluation (OMB No. 0930-0377)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ)
aims to complete a cross-site evaluation of SAMHSA's Strategic
Prevention Framework for Prescription Drugs (SPF-Rx). SPF-Rx is
designed to address nonmedical use of prescription drugs as well as
opioid overdoses by raising awareness about the dangers of sharing
medications and by working with pharmaceutical and medical communities
on the risks of overprescribing. The SPF-Rx program aims to promote
collaboration between states/tribes and pharmaceutical and medical
communities to understand the risks of overprescribing to youth ages
12-17 and adults 18 years of age and older. The program also aims to
enhance capacity for, and access to, Prescription Drug Monitoring
Program (PDMP) data for prevention purposes. This request for data
collection includes a revision from previously approved OMB
instruments.
The SPF-Rx program's indicators of success are reductions in opioid
overdoses, reductions in prescription drug misuse, and improved use of
PDMP data. Data collected through the tools described in this statement
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx
program. This package covers continued data collection through 2023.
The PEPC team will systematically collect and maintain an Annual
Implementation Instrument (AII) and Grantee and Community Level
Outcomes data modules submitted by SPF-Rx grantees through the online
Data Management System (DMS).
SAMHSA is requesting approval for data collection for the SPF-Rx
cross-site evaluation with the following instruments:
Annual Implementation Instrument (AII)--The AII is a
survey instrument collected yearly to monitor state, tribal entity, and
community-level performance, and to evaluate the effectiveness of the
SPF-Rx program. This tool is completed by grantees and subrecipient
community project directors, and provides process data related to
funding use and effectiveness, organizational capacity, collaboration
with community partners, data infrastructure, planned intervention
targets, intervention implementation, evaluation, contextual factors,
training and technical assistance (T/TA) needs, and sustainability.
Grantee-and Community-Level Outcomes Modules--These
modules collect data on key SPF-Rx program outcomes, including opioid
prescribing patterns and provider use of PDMP. Grantees will provide
outcomes data at the grantee level for their state, tribal area, or
jurisdiction, as well as at the community level for each of their
subrecipient communities.
Grantee-Level Interview--This qualitative interview will
be
[[Page 27757]]
administered at the end of the evaluation to obtain information from
the grantee project directors on their programs, staffing, populations
of focus, infrastructure, capacity, lessons learned, and collaboration.
Annualized Data Collection Burden by Year
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Annual implementation instrument 148 1 148 4 592
Grantee-Level Outcomes Module... 25 1 25 2.5 62.5
Community-Level Outcomes Module. 25 4.92 123 1.25 153.75
Grantee-Level Interview......... 25 1 25 1.5 37.5
-------------------------------------------------------------------------------
FY2021...................... 223 .............. 321 .............. 845.75
Annual Implementation Instrument 148 1 148 4 592
Grantee-Level Outcomes Module... 25 1 25 2.5 62.5
Community-Level Outcomes Module. 25 4.92 123 1.25 154.75
-------------------------------------------------------------------------------
FY2022...................... 198 .............. 296 .............. 808.25
Annual Implementation Instrument 39 1 39 4 156
Grantee-Level Outcomes Module... 7 1 7 2.5 17.5
Community-Level Outcomes Module. 7 4.57 32 1.25 40
-------------------------------------------------------------------------------
FY2023...................... 53 .............. 78 .............. 213.5
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Carlos Graham,
Social Science Analyst.
[FR Doc. 2020-09961 Filed 5-8-20; 8:45 am]
BILLING CODE 4162-20-P
